1. 于金明 中国 山东第一医科大学 中国工程院院士 Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with meta..
2. 贺林 中国 上海交通大学 中国科学院院士 Genetic Association of Curative and Adverse Reactions to Tyrosine Kinase Inhibitors in Chinese advan..
3. Daniel J,George 美国 Duke University Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metast..
4. Felix Y,Feng 美国 University of California-San Francisco Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metast..
5. Karen E,Knudsen 美国 Thomas Jefferson University Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metast..
6. Atsushi,Kumanogoh 日本 Osaka University Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EG..
7. 张力 中国 中山大学 Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy
8. Oscar,Arrieta 墨西哥 Institute Nacl Cancerol Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improve..
9. Kumar, Rakesh 印度 All India Institute of Medical Sciences, New Delhi Response to Oral Erlotinib Monotherapy in a Patient With EGFR-Negative Status in Histology and Progr..
10. Marc,Buyse 比利时 Hasselt University The Net Benefit of a treatment should take the correlation between benefits and harms into account
11. Erica A,Golemis 美国 Fox Chase Cancer Center Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging The..
12. Borghaei, Hossein 美国 Fox Chase Cancer Center Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging The..
13. Smith, Carl Inge Edvard 瑞典 Karolinska Institute Comparative Analysis of BTK Inhibitors and Mechanisms Underlying Adverse Effects
14. Alexei,Vazquez 英国 University of Glasgow Trends in Phase II Trials for Cancer Therapies
15. Howard,Gurney 澳大利亚 Macquarie University Cardiovascular Toxicity of Targeted Therapies for Cancer: An Overview of Systematic Reviews
16. Claire M,Vajdic 澳大利亚 University of New South Wales Cardiovascular Toxicity of Targeted Therapies for Cancer: An Overview of Systematic Reviews
17. Marina N,Nikiforova 美国 University of Pittsburgh KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel dis..
18. David L,Bartlett 美国 University of Pittsburgh KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel dis..
19. Aatur D,Singhi 美国 University of Pittsburgh KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel dis..
20. 杨明 中国 山东第一医科大学 Drug resistance to targeted therapeutic strategies in non-small cell lung cancer